Bioequivalence Study Design

Bioequivalence Study Design is the pre-specified methodological framework for a clinical pharmacokinetic study that compares the rate and extent of systemic exposure to an active ingredient from a test and a reference medicinal product, defining the experimental structure, study conditions, and statistical procedures required to determine compliance with regulatory bioequivalence criteria.

945

Publications

34.2K

Citations

3.7K

Authors

1.1K

Institutions

Publications per year

2017–2026

137

Authors

3.7K

  1. LE
    László Endrényi

    University of Toronto, Canada

    26 publications · 813 citations

    18

    h-index

  2. SC
    Shein‐Chung Chow

    Duke University, United States

    24 publications · 949 citations

    16

    h-index

  3. JL
    Jen‐pei Liu

    National Health Research Institutes, Taiwan

    14 publications · 448 citations

    13

    h-index

  4. LT
    László Tóthfalusi

    Semmelweis University, Hungary

    16 publications · 475 citations

    13

    h-index

  5. WW
    Walter W. Hauck

    Thomas Jefferson University, United States

    13 publications · 1K citations

    13

    h-index

1–5 of 3.7K

Venues

  1. Pharmaceutical Research

    42 publications · 2.1K citations

    25

    h-index

  2. PubMed

    Repository · 59 publications · 1.7K citations

    23

    h-index

  3. The Journal of Clinical Pharmacology

    42 publications · 1.3K citations

    22

    h-index

  4. Statistics in Medicine

    35 publications · 1.1K citations

    20

    h-index

  5. 16

    h-index

1–5